SCHEMBL2436646

SCHEMBL2436646

Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](N(C)C(=O)O)C(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.53
ABCB11 O95342 2/20 0.53
ABCB1 P08183 2/20 0.53
ABCG2 Q9UNQ0 2/20 0.53
KCNH2 Q12809 2/20 0.53
ABCC3 O15438 1/20 0.53
ABCC4 O15439 1/20 0.53
PGR P06401 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CHRM1 P11229 1/20 0.53
TBXA2R P21731 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
HTR2B P41595 1/20 0.53
SCN5A Q14524 1/20 0.53
CTSD P07339 4/20 0.49
UGT1A1 P22309 3/20 0.47
MLNR O43193 1/20 0.47
NR1I2 O75469 1/20 0.47
SLCO2B1 O94956 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436018 1.00 CYP3A4 (0.53) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL2435296 0.97 CYP3A4 (0.50) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL2435298 0.97 CYP3A4 (0.50) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL3805621 0.88 CYP3A4 (0.56) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL3802890 0.88 CYP3A4 (0.56) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL3798783 0.88 CYP3A4 (0.56) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL2438831 0.87 CYP3A4 (0.50) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL2436322 0.87 CYP3A4 (0.57) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL3102091 0.86 CYP3A4 (0.63) CYP3A4ABCB11ABCB1ABCG2KCNH2
SCHEMBL2433968 0.86 CYP3A4 (0.59) CYP3A4ABCB11ABCB1ABCG2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249181-A1 HIV Protease Inhibiting Compounds ABBOTT LABORATORIES (US) 2010-09-30 US claimed
US-20050148623-A1 Prevent reproduct of aids virus ABBVIE INC. 2005-07-07 US claimed
US-20050131017-A1 HIV protease inhibiting compounds ABBOTT LABORATORIES 2005-06-16 US claimed
EP-1697344-B1 HIV PROTEASE INHIBITING COMPOUNDS ABBOTT LAB (US) 2011-09-28 EP disclosed
US-7834043-B2 Prevent reproduct of aids virus ABBOTT LABORATORIES (US) 2010-11-16 US disclosed
US-20100249181-A1 HIV Protease Inhibiting Compounds ABBOTT LABORATORIES (US) 2010-09-30 US disclosed
US-20050148623-A1 Prevent reproduct of aids virus ABBVIE INC. 2005-07-07 US disclosed
US-20050131017-A1 HIV protease inhibiting compounds ABBOTT LABORATORIES 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148623-A1 Prevent reproduct of aids virus SERPINB1, PRSS1, SERPINA3 CYP3A4 481/4885ABCB11 2254/4885ABCB1 864/4885
US-20050131017-A1 HIV protease inhibiting compounds SERPINB1, HPN, DNPEP CYP3A4 764/4885ABCB11 2264/4885ABCB1 603/4885
US-20100249181-A1 HIV Protease Inhibiting Compounds SERPINB1, HPN, DNPEP CYP3A4 764/4885ABCB11 2264/4885ABCB1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.